Insomnia

Childhood-onset insomnia symptoms can be long-lasting, persisting into adolescence and even adulthood, according to a study published in Pediatrics.

Healio’s most-viewed neurology stories in January highlight several FDA developments, a Medicare proposal to limit Aduhelm coverage and a study on the role of Epstein-Barr virus infection in MS.

Quviviq 25 mg and 50 mg enhanced sleep among patients with insomnia disorder, according to results of two randomized, double-blind, placebo-controlled, phase 3 trials published in The Lancet Neurology.

The FDA granted approval to Quviviq to treat adults with insomnia.

Cognitive behavioral therapy for insomnia may help prevent major depression among older adults with insomnia disorder, according to results of a randomized clinical trial published in JAMA Psychiatry.

HF may be an independent predictor of insomnia symptoms, according to a presentation from the American Heart Association Scientific Sessions.

Older adults frequently used medication to treat sleep difficulties, according to study results presented at Psych Congress.

Untreated perinatal anxiety disorders and related stress or depression among mothers pose risks to offspring, according to a presenter at Psych Congress.

Small fiber neuropathy appears to have an increasing incidence rate, with greater trends toward obesity, according to study results published in Neurology.

Mindfulness-Based Therapy for Insomnia effectively improved subjective and objective sleep quality among older adults, according to results from a randomized clinical trial published in Psychological Medicine.